HLA and other host factors in transfusion-acquired HIV-1 infection

Human Immunology

Volumn 61, Issue 2, 2000, Pages 172-176

  Geczy, Andrew F ^a   Kuipers, Harmjan ^a   Coolen, Marcel ^a   Ashton, Lesley J ^b   Kennedy, Craig ^a   Ng, Gwen ^a   Dodd, Rebecca ^a   Wallace, Rhonda ^a   Le, Trang ^a   Raynes Greenow, Camille H ^a   Dyer, Wayne B ^a   Learmont, Jennifer C ^a   Sullivan, John S ^a  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

CCR2; CCR5; Disease progression; HIV 1; HLA

Indexed keywords

CHEMOKINE RECEPTOR CCR5; HLA ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; CLINICAL ARTICLE; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE COURSE; HLA TYPING; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AGED; ALLELES; BLOOD TRANSFUSION; CD4-CD8 RATIO; DISEASE PROGRESSION; FEMALE; GENES, MHC CLASS I; GENOTYPE; HISTOCOMPATIBILITY TESTING; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, CHEMOKINE; VIRAL LOAD;

EID: 0033972944     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00142-1     Document Type: Conference Paper

References (28)

1. Munoz A., Kirby A.J., He Y.D., Margolick J.B., Visscher B.R., Rinaldo C.R., Kaslow R.A., Phair J.P. Long-term survivors with HIV-1 infection incubation period and longitudinal patters of CD4+ lymphocytes . J Acquir Immune Defic Syndr. 8:1995;496.
2. Levy J.A. HIV-1 pathogenesis and long-term survival. AIDS. 7:1993;1401.
3. Buchbinder S.P., Katz M.H., Hessol N.A., O'Malley P.M., Holmberg S.D. Long-term HIV-1 infection without immunological progression. AIDS. 8:1994;1123.
4. Keet I.P.M., Krol A., Klein M.R., Veugulers P., de Wit J., Roos M., Koot M., Goudsmit J., Miedema F., Coutinho R.A. Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4+ cell counts. J Infect Dis. 169:1994;1236.
5. Winchester R., Charron D., Louie L., Mann D., Rubinstein P., Stevens C., Svejgaard A. The role of HLA in influencing the time of development of a particular outcome of HIV-1 infection. Charron D. Genetic diversity of HLA-functional and medical implication. 1997;EDK, Paris.
6. Chaisson R.E., Keruly J.C., Moore R.D. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med. 333:1995;751.
7. Phair J., Jacobson L., Detels R., Rinaldo C., Saah A., Schrager L., Munoz A. Acquired immune deficiency syndrome occurring within 5 years of infection with immunodeficiency virus type-1 the Multicenter AIDS Cohort study . J Acquir Immune Defic Syndr. 5:1992;490.
8. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., Berger E.A. CCCKR5 A RANTES, MIP-1α MIP-1β, Receptor as a fusion cofactor for macrophage-tropic HIV-1 . Science. 272:1996;1955.
9. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., DiMarzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661.
10. Smith M.W., Dean M., Carrington M., Winkler C., Huttley G.A., Lomb D.A., Goedert J.J., O'Brien T.R., Jacobson L.P., Kaslow R., Buchbinder S., Vittinghoff E., Vlahov D., Hoots K., Hilgartner M.W. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science. 277:1997;959.
11. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., Goedert J.J., Buchbinder S.P., Vittinghoff E., Gomperts E., Donfield S., Vlahov D., Kaslow R., Saah A., Rinaldo C., Detels R. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science. 273:1996;1856.
12. Michael N.L., Chang G., Louie L.G., Mascola J.R., Dondero D., Birx D.L., Sheppard H.W. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Med. 3:1997;338.
13. Stewart G.J., Ashton L.J., Biti R.A., Ffrench R.A., Bennetts B.H., Newcombe N.R., Benson E.M., Carr A., Cooper D.A., Kaldor J.M. Increased frequency of CCR-5Δ32 heterozygotes among long-term non-progressors with HIV-1 infection. AIDS. 11:1997;1833.
14. Morawetz R.A., Rizzardi G.P., Glauser D., Rutschmann O., Hirschel B., Perrin L., Opravil M., Flepp M., von Overbeck J., Glauser M.P., Ghezzi S., Vicenzi E., Poli G., Lazzarin A., Pantaleo G. Genetic polymorphism of CCR5 gene and HIV disease the heterozygous (CCR5/Δccr5) genotype is neither essential nor sufficient for protection against disease progression . Eur J Immunol. 27:1997;3223.
15. Garred P. Chemokine-receptor polymorphisms clarity or confusion for HIV-1 prognosis? Lancet. 351:1998;2.
16. Kostrikis L.G., Huang Y., Moore J.P., Wolinsky S.M., Zhank L., Guo Y., Deutsch L., Phair J., Newmann A.U., Ho D.D. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nature Med. 4:1998;350.
17. Michael N.L., Louie L.G., Rohrbaugh A.L., Schultz K.A., Dayhoff D.E., Wang C.E., Sheppard H.W. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nature Med. 3:1997;1160.
18. Rizzardi G.P., Morawetz R.A., Vicenzi E., Ghezzi S., Poli G., Lazzarin A., Pantaleo G. CCR2 polymorphism and HIV disease. Nature Med. 3:1998;252.
19. Learmont J., Cook L., Dunckley H., Sullivan J.S. Update on long-term symptomless HIV type 1 infection in recipients of blood products from a single donor. AIDS Res Hum Retroviruses. 11:1995;1.
20. Huang Y., Paxton W.A., Wolinsky S.M., Neumann A.U., Zhang L., He T., Kang S., Ceradini D., Jin Z., Yazdanbakhsh K., Kunstman K., Erickson D., Dragon E., Landau N.R., Phair J., Ho D.D., Koup R.A. The role of a CCR5 allele in HIV-1 transmission and disease progression. Nature Med. 2:1996;1240.
21. Day N.E., Breslow N.E. Statistical methods in cancer research. 1987;IARC Scientific Publications: Oxford University Press.
22. Roger M. Influence of host genes on HIV-1 disease progression. FASEB J. 12:1998;625.
23. Nelson G.W., Kaslow R., Mann D.L. Frequency of HLA allele-specific, peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection. Proc Natl Acad Sci USA. 94:1997;9802.
24. Cao Y., Qin L., Zhang L., Safrit J., Ho D.D. Virologic and immunologic characterisation of long-term survivors of human Immunodeficiency virus type 1 infection. N Engl J Med. 332:1995;201.
25. Pantaleo G., Menzo S., Vaccarezza M., Graziosi C., Cohen O.J., Demarest J.F., Montefiori D., Orenstein J.M., Fox C., Schrager L.K., Margolick J.B., Buchbinder S., Giorgi J., Fauci A.S. Studies in subjects with long-term non-progressive human Immunodeficiency virus infection. N Engl J Med. 332:1995;209.
26. Ioannidis J.P.A., O'Brien T.R., Rosenberg P.S., Contopoulos-Ioannidis D.G., Geodert J.J. Genetic effects on HIV disease progression. Nature Med. 4:1998;536.
27. Magierowska M, Costagliola D, Sanson F, Debre P, Theodorou I: Host's genetic background of HIV-1 infected long-term non-progressors in France. 12th World AIDS Conference, Geneva, Abstract 13346, 1998.
28. Lander E.S., Schork N. Genetic dissection of complex traits. Science. 265:1994;2037.